Balyasny Asset Management LLC Dbv Technologies S.A. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$2.33 - $12.98 $852,013 - $4.75 Million
-365,671 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$6.75 - $11.15 $2.47 Million - $4.08 Million
365,671 New
365,671 $3.91 Million
Q4 2017

Feb 14, 2018
SELL
$20.9 - $49.36 $313,500 - $740,400
-15,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$39.62 - $46.17 $594,300 - $692,550
15,000
15,000 $637,000

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $95.8M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email